MVision AI is a pioneering leader in medical imaging and radiation oncology software, specializing in AI-powered, guideline-based auto-contouring solutions. Founded by a dedicated team of medical physics and tech experts, MVision AI addresses a massive bottleneck in cancer care: the labor-intensive, highly variable process of manual contouring. Through its flagship platform, Workspace+, and its advanced GBS™ (Guideline-Based Segmentation) framework, MVision AI automates the delineation of organs-at-risk (OARs) and complex lymph node volumes across all major anatomical sites. By deploying sophisticated, cloud-based and local 3D deep learning models, MVision AI standardizes the foundation of treatment planning. The company's software-only medical devices are FDA-cleared and fully compliant with HIPAA and GDPR regulations. They seamlessly integrate into existing hospital IT infrastructures and treatment planning systems (TPS). Serving clinics worldwide, MVision AI helps oncology departments elevate standard of care, reduce patient wait times, and achieve unprecedented clinical efficiency—bridging the gap between intelligent automation and precise, human-led medical decisions. As the 2026 ASTRO Annual Meeting highlights the transformative integration of artificial intelligence in radiation oncology, visiting the MVision AI booth is essential for clinicians, dosimetrists, and department leaders looking to combat workforce shortages and clinical burnout. Experience Real-World Time Savings: Peer-reviewed clinical studies show that MVision’s Contour+ reduces manual contouring time by a median of 29% to 79%, cutting hours of tedious labor down to just minutes. See a live demonstration of how this efficiency can shave days off your clinic’s treatment planning turnaround times. Achieve Unmatched Consistency: Human contouring variability can impact treatment planning. MVision AI models are trained strictly on 25+ official international consensus guidelines (including ESTRO, RTOG, and UK SABR), reducing inter-observer contouring variability by 20% on average. Everyone on your team starts with the same high-quality, standardized foundation. Explore the Complete Workspace+ Ecosystem: Discover how MVision AI has evolved beyond standard auto-segmentation. Get hands-on with integrated capabilities that unify auto-contouring, synthetic imaging, dose prediction, and contour propagation into a singular, highly secure, scalable workflow platform. Witness Verified Clinical Acceptance: Independent data confirms that up to 87% of MVision’s automatically generated contours require either zero or only minor edits by radiation oncologists. At our booth, you can see the exceptional 3D modeling accuracy across more than 300 structures (including 90 distinct lymph node regions) for both CT and MR imaging. Seamless Integration, Zero Hardware Hassle: Learn how our secure, encrypted cloud setup allows for fast algorithm updates without forcing your hospital's IT department to manage complex, heavy local hardware configurations. Stop by the MVision AI booth at ASTRO 2026 to see how guideline-based AI can optimize your workflow, improve clinical confidence, and allow your department to refocus precious time where it matters most: on face-to-face patient care.